SCHEMBL2309682

SCHEMBL2309682

CCCC(F)OC(=O)NCC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.41
FAAH O00519 2/20 0.37
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
PTGS2 P35354 1/20 0.36
PLA2G2A P14555 1/20 0.35
MME P08473 1/20 0.35
ACE P12821 1/20 0.35
CPA1 P15085 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
ATM Q13315 1/20 0.34
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4778558 0.79 FAAH (0.40) FAAHCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL17748720 0.78 HDAC7 (0.36) TDP1MAPTCHRM1AKR1A1CHRM3
SCHEMBL5154142 0.76 ACHE (0.37) LMNACHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL14095233 0.75 MME (0.44) EGLN1TDP1ALDH1A1LMNAMAPT
SCHEMBL4300126 0.74
SCHEMBL5147543 0.73 EGLN1 (0.37) EGLN1FAAHTDP1ALDH1A1LMNA
SCHEMBL1276782 0.73 DPP7 (0.45) EPHX1
SCHEMBL9989327 0.73 HDAC7 (0.35) TDP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL5553307 0.72 LMNA (0.48) EGLN1TDP1ALDH1A1LMNAMAPT
SCHEMBL716434 0.72 CHRM1 (0.39) FAAHTDP1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016140878-A9 PRODRUGS RILUZOLE AND THEIR METHOD OF USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-10-20 WO disclosed
EP-3022198-A1 NOVEL 5-SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2016-05-25 EP disclosed
WO-2015007516-A1 NOVEL 5-SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-01-22 WO disclosed
EP-2350000-A1 PIPERAZINE DERIVATIVES FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE Bayer Schering Pharma Aktiengesellschaft (DE) 2011-08-03 EP disclosed
WO-2010028776-A1 PIPERAZINE DERIVATIVES FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-03-18 WO disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed